<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Alday-Parejo, Begoña</dc:creator>
  <dc:creator>Richard, François</dc:creator>
  <dc:creator>Wörthmüller, Janine</dc:creator>
  <dc:creator>Rau, Tilman</dc:creator>
  <dc:creator>Galván, José A.</dc:creator>
  <dc:creator>Desmedt, Christine</dc:creator>
  <dc:creator>Santamaria-Martinez, Albert</dc:creator>
  <dc:creator>Rüegg, Curzio</dc:creator>
  <dc:date>2020-01-16</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Membrane-associated guanylate kinase (MAGUK) with inverted domain  structure-1 (MAGI1) is an intracellular adaptor protein that stabilizes epithelial  junctions consistent with a tumor suppressive function in several cancers of  epithelial origin. Here we report, based on experimental results and human  breast cancer (BC) patients’ gene expression data, that MAGI1 is highly  expressed and acts as tumor suppressor in estrogen receptor (ER)+/HER2− but  not in HER2+ or triple negative breast cancer (TNBC). Within the ER+/HER2−  subset, high MAGI1 expression associates with ESR1 and luminal genes  GATA3 and FOXA1 expression and better prognosis, while low MAGI1 levels  correlates with higher histological grade, more aggressive phenotype and worse  prognosis. Experimentally, MAGI1 downregulation in the ER+ human BC cells  MCF7 impairs ER expression and signaling, promotes cell proliferation, and  reduces apoptosis and epithelial differentiation. MAGI1 downregulation in the  ER+ murine BC cell line 67NR accelerates primary tumor growth and enhances  experimental lung metastasis formation. MAGI1 expression is upregulated by  estrogen/ER, downregulated by prostaglandin E2/COX-2axis, and negatively  correlates with inflammation in ER+/HER2− BC patients. Taken together, we  show that MAGI1 is a new potential tumor suppressor in ER+/HER2− breast  cancer with possible prognostic value for the identification of patients at high- risk of relapse within this subset.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/308546</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/308546/files/rue_mnp.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers12010223</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Cancers. - 2020, vol. 12, no. 1, p. 223</dc:source>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Magi1, a new potential tumor suppressor gene in estrogen receptor positive breast cancer</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
